ADVI Health Appoints Rod Cavin and Scott Howell to Its Board of Directors

ADVI Health, a leading life sciences data and consulting services firm, is pleased to announce the addition of Rod Cavin and Scott Howell to its Board of Directors. These two highly respected healthcare executives bring extensive experience and expertise in the life sciences industry, particularly within pharmaceutical services. Their appointment is expected to drive ADVI Health's growth and market dominance.

Rod Cavin is a transformative entrepreneur and healthcare executive known for his forward-thinking approach and strategic planning skills. With over fifteen years of experience as CEO of Health Strategies Group, Rod has successfully built and scaled businesses, achieving double-digit growth. Under his leadership, Health Strategies Group was sold to EVERSANA in 2017. Rod's expertise spans corporate governance, financial planning, leadership development, and business partnership development. He has in-depth knowledge of the life sciences, bio-pharmaceutical, and medical device industries, with a focus on therapeutic areas such as oncology, rare diseases, cardiology, and digital therapeutics.

Scott Howell M.D. brings a wealth of experience as an accomplished healthcare general manager and strategist. He has worked across various healthcare segments, including medical practice and administration, managed care, pharmaceuticals and biotech, distribution, specialty pharmacy, and consulting. With expertise in drug pricing, reimbursement, market access, and patient services, Scott has held strategic positions at renowned biopharmaceutical manufacturers such as Novartis, Jazz, Genentech, and GSK. He has also made significant contributions at Cardinal Health and Highmark BCBS. Scott is a respected speaker, author, and guest lecturer at prestigious MBA and MPH programs.

Marc Samuels, CEO of ADVI Health, expressed his confidence in Rod and Scott's abilities, stating that their strong commercial leadership skills and extensive background in M&A deal-making perfectly complement ADVI Health's Board. He believes that their guidance will play a pivotal role in the company's rapid growth and market dominance.

ADVI Health is dedicated to providing strategic consulting services to the healthcare and life sciences ecosystem. With offices in Austin, Chicago, San Francisco, and Washington, DC, the firm excels in solving complex problems in healthcare through data-informed commercialization, market access, and policy expertise. ADVI Health offers insights, products, and services across the product lifecycle and is committed to helping clients succeed in managed services, medtech, pharma, and precision medicine. Its Strategic Analytics and Value Economics (SAVEs) data capabilities cover multiple payers and provide clients with invaluable insights and competitive intelligence.

ADVI Health's partnership with Rod Cavin and Scott Howell represents its commitment to delivering exceptional value to clients. With their extensive industry knowledge and experience, the company is poised to accelerate growth, build enduring value, and achieve outstanding results. The addition of these two seasoned professionals to ADVI Health's Board of Directors marks an exciting chapter in the company's journey towards becoming a market leader.

For more information about ADVI Health and its services, please visit their website at www.advi.com.

About ADVI Health:

ADVI Health is a leading life sciences data and consulting services firm that serves as a strategic consulting partner to the healthcare and life sciences ecosystem. With expertise in commercialization, market access, and policy, ADVI Health helps clients navigate the complexities of the healthcare industry and achieve success. The company's Strategic Analytics and Value Economics (SAVEs) data capabilities provide valuable insights and competitive intelligence to support informed decision-making. With a focus on managed services, medtech, pharma, and precision medicine, ADVI Health is dedicated to helping clients succeed across the product lifecycle.

About Sheridan Capital Partners:

Sheridan Capital Partners is a healthcare private equity firm based in Chicago. The firm specializes in lower middle market buyouts and growth equity investments in the United States and Canada. Sheridan partners with companies in providers and provider services, healthcare IT and outsourced services, and consumer health and medical products verticals. By providing strategic resources, Sheridan accelerates growth, builds enduring value, and achieves strong results for its portfolio companies.